HIV-associated bladder cancer: A case series evaluating difficulties in diagnosis and management

被引：24

作者：

Gaughan E.M. ^{[1
]}

Dezube B.J. ^{[1
]}

Bower M. ^{[2
]}

Aboulafia D.M. ^{[3
]}

Bohac G. ^{[4
]}

Cooley T.P. ^{[5
]}

Pantanowitz L. ^{[6
]}

机构：

[1] Department of Medicine (Hematology-Oncology), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

[2] Department of Oncology, Chelsea and Westminster Hospital, London

[3] Division of Hematology and Oncology, Virginia Mason Clinic, University of Washington, Seattle, WA

[4] Department of Medicine, Rush University, Chicago, IL

[5] Department of Medicine, Lahey Clinic, Burlington, MA

[6] Department of Pathology, School of Medicine, Tufts University, Springfield, MA

来源：

BMC Urology | / 9卷 / 1期

关键词：

Human Immunodeficiency Virus; Bladder Cancer; Human Immunodeficiency Virus Infection; Human Papilloma Virus; Bladder Tumor;

D O I：

10.1186/1471-2490-9-10

中图分类号：

学科分类号：

摘要：

Background. Chronic human immunodeficiency virus (HIV) infection is associated with an increased incidence of Non-Acquired Immunodeficiency Syndrome (non-AIDS) defining cancers. To date, only a limited number of cases of bladder cancer have been linked with HIV infection. We sought to describe the clinical characteristics of HIV-associated bladder cancer. Methods. A retrospective study was performed involving HIV-positive patients with bladder cancer, combining cases from multiple institutions with published case reports. Data regarding patient demographics, HIV status, clinical presentation, pathology, cancer treatment, and outcome were analyzed using descriptive statistics. Results. Eleven patients were identified with a median age of 55 years (range, 33 - 67). The median CD4+ count at cancer diagnosis was 280 cells/mm3 (range, 106 - 572 cells/mm3). Six patients (55%) had a known risk factor for bladder cancer, and nine (82%) presented with hematuria. Ten patients had transitional cell carcinoma, and most had superficial disease at presentation. Treatment included mainly transurethral resection of bladder tumor followed by a combination of local and systemic therapies. One patient received intravesical bacillus Calmette-Guèrin (BCG) without complication. Several patients (55%) were alive following therapy, although many (64%) suffered from local relapse and metastatic disease. Conclusion. Bladder cancer is part of the growing list of cancers that may be encountered in patients living longer with chronic HIV-infection. Our patients presented at a younger age and with only mild immunosuppression, however, they experienced an expected course for their bladder cancer. Hematuria in an HIV-infected patient warrants a complete evaluation. © 2009 Gaughan et al; licensee BioMed Central Ltd.

引用

共 30 条

[1]

Pantanowitz L., Schlecht H.P., Dezube B.J., The growing problem of non-AIDS-defining malignancies in HIV, Curr Opin Oncol, 18, 5, pp. 469-78, (2006)

[2]

Al Soub H., Transitional cell carcinoma of the bladder in an HIV-infected patient, Postgrad Med J, 72, 847, pp. 302-4, (1996)

[3]

Clemente Ramos L.M., Fernandez Fernandez E., Sanchez-Encinas M., Garcia Gonzalez R., Escudero Barrilero E., Fatal bladder carcinoma in a young man with human immunodeficiency virus, Br J Urol, 82, 1, pp. 132-3, (1998)

[4]

Wolf D., HIV-infected patient with macrohematuria. Urothelial carcinoma of the urinary bladder (Article in German), Schweiz Rundsch Med Prax, 90, 25-26, pp. 1159-61, (2001)

[5]

Santos J., Palacios R., Ruiz J., Gonzalez M., Marquez M., Unusual malignant tumors in patients with HIV infection, Int J STD AIDS, 13, 10, pp. 674-6, (2002)

[6]

Manfredi R., Sabbatani S., Calza L., Chiodo F., Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: A rare, but intriguing association. Two case reports and literature review, Scandinavian Journal of Infectious Diseases, 38, 6-7, pp. 566-570, (2006)

[7]

Patil P., Elem B., Zumla A., Pattern of adult malignancies in Zambia (1980-1989) in light of the human immunodeficiency virus type 1 epidemic, J Trop Med Hyg, 98, 4, pp. 281-4, (1995)

[8]

Wabinga H.R., Parkin D.M., Wabwire-Mangen F., Mugerwa J.W., Cancer in Kampala, Uganda, in 1989-91: Changes in incidence in the era of AIDS, Int J Cancer, 54, 1, pp. 26-36, (1993)

[9]

Frisch M., Biggar R.J., Engels E.A., Association of cancer with AIDS-related immunosuppression in adults, JAMA, 285, 13, pp. 1736-45, (2001)

[10]

Grulich A.E., Van Leeuwen M.T., Falster M.O., Vajdic C.M., Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis, Lancet, 370, 9581, pp. 59-67, (2007)

← 1 2 3 →